EPISODE · Feb 14, 2023 · 59 MIN
Episode 120: For Blood and Money: A Biotech Story
from Healthcare Unfiltered · host Chadi Nabhan
Nathan Vardi, managing editor at MarketWatch, and author of the new book “For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug,” is the guest of honor on today’s show. Nathan divulges on what happened behind closed doors for the creation of BTK inhibitors. Everything at the intersection of Wall Street, investigators, doctors, regulatory agencies, investors, and VC is detailed. He begins by explaining the inspiration to cover this story and how willing individuals were to speak on the record, describes in detail a few of the nuances of and feelings toward specific characters, provides examples of the role that luck plays in cancer drug development, and opines on the FDA’s challenge of approving the right drugs for market, among many other fascinating topics.Read more about “For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug.”https://wwnorton.com/books/9780393540956Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
Embed this episode
What this episode covers
Nathan Vardi, managing editor at MarketWatch, and author of the new book “For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug,” is the guest of honor on today’s show. Nathan divulges on what happened behind closed doors for the creation of BTK inhibitors. Everything at the intersection of Wall Street, investigators, doctors, regulatory agencies, investors, and VC is detailed. He begins by explaining the inspiration to cover this story and how willing individuals w...
NOW PLAYING
Episode 120: For Blood and Money: A Biotech Story
No transcript for this episode yet
Similar Episodes
No similar episodes found.